- Home
- ONCO vs EVOK Comparison
ONCO vs EVOK Comparison
Compare ONCO & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCO
- EVOK
- Stock Information
- Founded
- ONCO 2018
- EVOK 2007
- Country
- ONCO United States
- EVOK United States
- Employees
- ONCO N/A
- EVOK N/A
- Industry
- ONCO Biotechnology: Pharmaceutical Preparations
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- ONCO Health Care
- EVOK Health Care
- Exchange
- ONCO Nasdaq
- EVOK Nasdaq
- Market Cap
- ONCO 9.4M
- EVOK 7.1M
- IPO Year
- ONCO 2022
- EVOK 2013
- Fundamental
- Price
- ONCO $0.56
- EVOK $4.88
- Analyst Decision
- ONCO
- EVOK
- Analyst Count
- ONCO 0
- EVOK 0
- Target Price
- ONCO N/A
- EVOK N/A
- AVG Volume (30 Days)
- ONCO 10.4M
- EVOK 9.6K
- Earning Date
- ONCO 12-10-2024
- EVOK 03-13-2025
- Dividend Yield
- ONCO N/A
- EVOK N/A
- EPS Growth
- ONCO N/A
- EVOK N/A
- EPS
- ONCO N/A
- EVOK N/A
- Revenue
- ONCO $1,870,605.00
- EVOK $8,617,036.00
- Revenue This Year
- ONCO N/A
- EVOK $97.35
- Revenue Next Year
- ONCO N/A
- EVOK $99.52
- P/E Ratio
- ONCO N/A
- EVOK N/A
- Revenue Growth
- ONCO N/A
- EVOK 100.35
- 52 Week Low
- ONCO $0.32
- EVOK $3.54
- 52 Week High
- ONCO $21.40
- EVOK $12.32
- Technical
- Relative Strength Index (RSI)
- ONCO 44.48
- EVOK 50.36
- Support Level
- ONCO $0.55
- EVOK $4.68
- Resistance Level
- ONCO $0.70
- EVOK $5.00
- Average True Range (ATR)
- ONCO 0.10
- EVOK 0.27
- MACD
- ONCO 0.01
- EVOK 0.02
- Stochastic Oscillator
- ONCO 18.44
- EVOK 42.45
About ONCO Onconetix Inc.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.